| ||
| ||
Pharma industry unhappy with Govt decision on FDI Economic Times NEW DELHI: Pharmaceutical industry today criticised the government's decision to make it mandatory for all foreign investments in existing domestic pharma firms to be cleared by the FIPB. Reacting against the decision, Biocon Chairman and Managing ... See all stories on this topic » | ||
First Committee on Drugs of Japan's Pharmaceutical Affairs reviews Novo ... pharmabiz.com Novo Nordisk, a global healthcare company, announced that Ryzodeg (insulin degludec/insulin aspart) has passed the review by the First Committee on Drugs of Japan's Pharmaceutical Affairs. The remaining step in the regulatory process is an approval ... See all stories on this topic » | ||
Ruling Is Victory for Drug Companies in Promoting Medicine for Other Uses New York Times In a case that could have broad ramifications for the pharmaceutical industry, a federal appeals court on Monday threw out the conviction of a sales representative who sold a drug for uses not approved by the Food and Drug Administration. The judges ... See all stories on this topic » | ||
Galena, Teva Pharmaceutical Agree to Commercialization Deal in Israel Wall Street Journal Biotechnology company Galena Biopharma Inc. (GALE) signed a deal with Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) to develop and commercialize NeuVax in Israel, bringing Galena's lead breast cancer treatment to a new market. Galena's ... See all stories on this topic » | ||
| ||
Biostar Pharmaceuticals, Inc. Signs an $8 Million Agreement to Manufacture and ... Sacramento Bee XIANYANG, China, Dec. 4, 2012 -- /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of ... See all stories on this topic » | ||
Jazz Pharmaceuticals Begins Clinical Trial of Intravenously Administered ... Sacramento Bee DUBLIN, Dec. 3, 2012 -- /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled and dosed in a clinical trial of Erwinaze® (asparaginase Erwinia chrysanthemi) administered intravenously (IV) as ... See all stories on this topic » | ||
SCICLONE PHARMACEUTICALS, INC. : SciClone Announces New ZADAXIN(R ... 4-traders FOSTER CITY, CA -- (Marketwire) -- 12/04/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that its newly created anti-counterfeiting Pharma-Comb Void label for ZADAXIN has won the prestigious "Innovator Award" in the annual ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment